# Reviva Pharmaceuticals Holdings, Inc.: Form 8-K, filed Mar 19, 2026

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: 8-K
- Filed: 2026-03-19
- Accepted by EDGAR: Mar 19, 2026, 16:17 ET
- Period: 2026-03-18
- Accession: 0001437749-26-009063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774926009063/rvph20260319_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774926009063/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774926009063/rvph20260319_8k.htm

Filed Mar 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-009063. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.